Does GADODIAMIDE Cause Nephrogenic systemic fibrosis? 99 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 99 reports of Nephrogenic systemic fibrosis have been filed in association with GADODIAMIDE (OMNISCAN). This represents 12.7% of all adverse event reports for GADODIAMIDE.
99
Reports of Nephrogenic systemic fibrosis with GADODIAMIDE
12.7%
of all GADODIAMIDE reports
17
Deaths
10
Hospitalizations
How Dangerous Is Nephrogenic systemic fibrosis From GADODIAMIDE?
Of the 99 reports, 17 (17.2%) resulted in death, 10 (10.1%) required hospitalization, and 4 (4.0%) were considered life-threatening.
Is Nephrogenic systemic fibrosis Listed in the Official Label?
Yes, Nephrogenic systemic fibrosis is listed as a known adverse reaction in the official FDA drug label for GADODIAMIDE.
What Other Side Effects Does GADODIAMIDE Cause?
Pain (216)
Gadolinium deposition disease (199)
Arthralgia (194)
Rash (188)
Paraesthesia (183)
Fatigue (175)
Asthenia (174)
Burning sensation (172)
Injury (171)
Confusional state (169)
What Other Drugs Cause Nephrogenic systemic fibrosis?
OMNISCAN (658)
GADOLINIUM (370)
MAGNEVIST (322)
OPTIMARK (121)
PROHANCE (85)
MULTIHANCE (77)
GADOPENTETATE DIMEGLUMINE (60)
GADOTERATE MEGLUMINE (36)
GADOBENATE DIMEGLUMINE (35)
GADOTERIDOL (31)
Which GADODIAMIDE Alternatives Have Lower Nephrogenic systemic fibrosis Risk?
GADODIAMIDE vs GADOLINIUM
GADODIAMIDE vs GADOPENTETATE DIMEGLUMINE
GADODIAMIDE vs GADOPICLENOL
GADODIAMIDE vs GADOTERATE MEGLUMINE
GADODIAMIDE vs GADOTERIDOL